Drawing for TREXIJECT

USPTO serial 87222124

TREXIJECT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ROSEN, AMANDA
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TREXIJECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Haverly MacArthur

HAVERLY MACARTHUR ADAMS AND REESE LLP424 CHURCH STREET SUITE 2700NASHVILLE, TN 37219UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-arthritic compositions and preparations; analgesic compositions and preparations; chemical preparations for pharmaceutical or medical purposes for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the prevention and treatment of auto immune diseases and disorders; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for auto immune diseases and inflammatory diseases; pharmaceutical preparations for auto immune diseases and inflammatory diseases, such as arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical products for the treatment of joint diseaseABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2017MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Nov 17, 2017ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Nov 17, 2017OP.TOPPOSITION TERMINATED NO. 999999—
Nov 17, 2017OP.SOPPOSITION SUSTAINED NO. 999999—
Aug 9, 2017OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 8, 2017OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Aug 3, 2017IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 25, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 11, 2017ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jan 31, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 31, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 31, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 11, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 20, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 15, 2016DOCKASSIGNED TO EXAMINER—
Nov 4, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance